{
  "zip": "3067",
  "sector": "Healthcare",
  "longBusinessSummary": "Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.",
  "city": "Abbotsford",
  "phone": "61 3 8532 2700",
  "state": "VIC",
  "country": "Australia",
  "companyOfficers": [],
  "website": "http://starpharma.com",
  "maxAge": 1,
  "address1": "4-6 Southampton Crescent",
  "fax": "61 3 9510 5955",
  "industry": "Biotechnology",
  "previousClose": 1.16,
  "regularMarketOpen": 1.16,
  "twoHundredDayAverage": 0.9917986,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 1.16,
  "navPrice": null,
  "averageDailyVolume10Day": 812,
  "totalAssets": null,
  "regularMarketPreviousClose": 1.16,
  "fiftyDayAverage": 1.0951515,
  "trailingAnnualDividendRate": null,
  "open": 1.16,
  "averageVolume10days": 812,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.316649,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 1.16,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 3000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 473332192,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 1288,
  "priceToSalesTrailing12Months": null,
  "dayLow": 1.16,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 3000,
  "fiftyTwoWeekHigh": 1.3,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.39,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 1.16,
  "exchange": "PNK",
  "shortName": "STARPHARMA HOLDINGS LIMITED",
  "longName": "Starpharma Holdings Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SPHRF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_4493458",
  "uuid": "14970361-6a9a-3e44-8fcc-632c0d1d6166",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -2.21856,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 406015008,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1593475200,
  "heldPercentInstitutions": 0.42306,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.09632,
  "nextFiscalYearEnd": 1656547200,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 344978146,
  "enterpriseValue": 432172704,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 1.16,
  "logo_url": "https://logo.clearbit.com/starpharma.com"
}